Nirsevimab and a Community Recall-Based Immunization Strategy for Child Bronchiolitis Prevention

This cohort study examines the association of a recall-based nirsevimab immunization strategy with the incidence of clinically diagnosed all-cause bronchiolitis during the 2024-2025 respiratory syncytial virus season in Italy.

Institutions

Publication Details

Journal
JAMA Network Open
Published
2026-05-19
DOI
https://doi.org/10.1001/jamanetworkopen.2026.13571
Primary Topic
Respiratory viral infections research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Nirsevimab and a Community Recall-Based Immunization Strategy for Child Bronchiolitis Prevention

JAMA Network Open
Respiratory viral infections research
article

Nirsevimab and a Community Recall-Based Immunization Strategy for Child Bronchiolitis Prevention

article en

Abstract

This cohort study examines the association of a recall-based nirsevimab immunization strategy with the incidence of clinically diagnosed all-cause bronchiolitis during the 2024-2025 respiratory syncytial virus season in Italy.

JAMA Network OpenVol. 9(5)
University of Padua (IT), University of Milano-Bicocca (IT)
Openalex Percentile: Top 5%
Respiratory viral infections research
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Nirsevimab and a Community Recall-Based Immunization Strategy for Child Bronchiolitis Prevention · JAMA Network Open (2026) | TGRS Research Map | TGRS